Fungal infections remain hardly treatable because of unstandardized diagnostic tests,
limited antifungal armamentarium, and more specifically, potential toxic interactions between …

COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
and has infected over 200 million people, causing over 4 million deaths. COVID-19 infection …

COVID-19 pandemic highlighted the complications of secondary fungal infections that
occurred globally in severe cases of coronavirus disease managed in the intensive care …

Background Notable fungal coinfections with SARS-CoV-2 in COVID-19 patients have been
reported worldwide in an alarming way. Mucor spp. and Rhizopus spp. were commonly …

Secondary fungal infections may complicate the clinical course of patients affected by viral
respiratory diseases, especially those admitted to intensive care unit. Hospitalized COVID …

Patients with severe COVID-19, such as individuals in intensive care units (ICU), are
exceptionally susceptible to bacterial and fungal infections. The most prevalent fungal …

The COVID-19 pandemic caused> 6 million deaths worldwide, often from respiratory failure.
Complications frequently occurred in hospitalized patients, particularly in the intensive care …

Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …

SUMMARY COVID-19 is frequently associated with the onset of secondary infections,
especially in severe cases treated in the intensive care unit. While bacterial pathogens are …

Severe cases of coronavirus disease 2019 (COVID-19) managed in the intensive care unit
are prone to complications, including secondary infections with opportunistic fungal …